Krsnaa Diagnostics [KRSNAA] vs Qualitek Labs [QLL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Krsnaa Diagnostics Ltd. wins in 10 metrics, Qualitek Labs Ltd. wins in 7 metrics, with 0 ties. Krsnaa Diagnostics Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Krsnaa Diagnostics Ltd. | Qualitek Labs Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.69 | 37.58 | Krsnaa Diagnostics Ltd. |
| Price-to-Book Ratio | 2.13 | 2.57 | Krsnaa Diagnostics Ltd. |
| Debt-to-Equity Ratio | 30.96 | 50.78 | Krsnaa Diagnostics Ltd. |
| PEG Ratio | -1.15 | N/A | N/A |
| EV/EBITDA | 10.20 | 26.91 | Krsnaa Diagnostics Ltd. |
| Profit Margin (TTM) | 10.49% | 8.97% | Krsnaa Diagnostics Ltd. |
| Operating Margin (TTM) | 13.13% | 15.25% | Qualitek Labs Ltd. |
| EBITDA Margin (TTM) | 13.13% | 15.25% | Qualitek Labs Ltd. |
| Return on Equity | 8.79% | 12.27% | Qualitek Labs Ltd. |
| Return on Assets (TTM) | 6.06% | 7.21% | Qualitek Labs Ltd. |
| Free Cash Flow (TTM) | $-393.00M | $-128.53M | Qualitek Labs Ltd. |
| Dividend Yield | 0.62% | N/A | N/A |
| 1-Year Return | -21.15% | 43.88% | Qualitek Labs Ltd. |
| Price-to-Sales Ratio (TTM) | 2.56 | 5.12 | Krsnaa Diagnostics Ltd. |
| Enterprise Value | $21.08B | $4.38B | Krsnaa Diagnostics Ltd. |
| EV/Revenue Ratio | 2.75 | 6.24 | Krsnaa Diagnostics Ltd. |
| Gross Profit Margin (TTM) | 70.12% | N/A | N/A |
| Revenue per Share (TTM) | $237 | $79 | Krsnaa Diagnostics Ltd. |
| Earnings per Share (Diluted) | $24.48 | $9.58 | Krsnaa Diagnostics Ltd. |
| Beta (Stock Volatility) | -0.03 | -0.11 | Qualitek Labs Ltd. |
Krsnaa Diagnostics Ltd. vs Qualitek Labs Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Krsnaa Diagnostics Ltd. | 0.83% | 0.61% | -7.81% | -10.16% | -28.11% | -27.24% |
| Qualitek Labs Ltd. | -0.04% | 0.22% | 15.46% | 32.25% | 2.48% | 4.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Krsnaa Diagnostics Ltd. | -21.15% | -7.70% | -42.36% | -42.36% | -42.36% | -42.36% |
| Qualitek Labs Ltd. | 43.88% | 141.56% | 141.56% | 141.56% | 141.56% | 141.56% |
Performance & Financial Health Analysis: Krsnaa Diagnostics Ltd. vs Qualitek Labs Ltd.
| Metric | KRSNAA | QLL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹19.83B | ₹3.59B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 48,338 | 8,240 |
| 90 Day Avg. Volume | 67,120 | 7,253 |
| Last Close | ₹538.75 | ₹409.90 |
| 52 Week Range | ₹515.00 - ₹894.40 | ₹258.55 - ₹458.95 |
| % from 52W High | -39.76% | -10.69% |
| All-Time High | ₹1,099.70 (Aug 16, 2021) | ₹458.95 (Sep 19, 2025) |
| % from All-Time High | -51.01% | -10.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | N/A |
| Quarterly Earnings Growth | -0.22% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.09% |
| Operating Margin (TTM) | 0.13% | 0.15% |
| Return on Equity (TTM) | 0.09% | 0.12% |
| Debt to Equity (MRQ) | 30.96 | 50.78 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹284.46 | ₹140.22 |
| Cash per Share (MRQ) | ₹40.22 | ₹0.46 |
| Operating Cash Flow (TTM) | ₹2.45M | ₹104.99M |
| Levered Free Cash Flow (TTM) | ₹776.08M | ₹-329,006,240 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.62% | N/A |
| Last 12-Month Dividend | ₹5.25 | N/A |
Valuation & Enterprise Metrics Analysis: Krsnaa Diagnostics Ltd. vs Qualitek Labs Ltd.
| Metric | KRSNAA (Apr 24, 2026) | QLL (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.69 | 37.58 |
| Forward P/E | 14.79 | N/A |
| PEG Ratio | -1.15 | N/A |
| Price to Sales (TTM) | 2.56 | 5.12 |
| Price to Book (MRQ) | 2.13 | 2.57 |
| Market Capitalization | ||
| Market Capitalization | ₹19.83B | ₹3.59B |
| Enterprise Value | ₹21.08B | ₹4.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.75 | 6.24 |
| Enterprise to EBITDA | 10.20 | 26.91 |
| Risk & Other Metrics | ||
| Beta | -0.03 | -0.11 |
| Book Value per Share (MRQ) | ₹284.46 | ₹140.22 |
Financial Statements Comparison: Krsnaa Diagnostics Ltd. vs Qualitek Labs Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | KRSNAA (2025) | QLL (2025) |
|---|---|---|
| Revenue/Sales | 7.17B | 702.27M |
| Cost of Goods Sold | 2.30B | 102.02M |
| COGS % of Revenue | 32.1% | 14.5% |
| Gross Profit | 4.87B | 600.25M |
| Gross Margin | 67.9% | 85.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.02B | 124.96M |
| Operating Margin | 14.2% | 17.8% |
| EBITDA | 2.08B | 170.94M |
| EBITDA Margin | 29.0% | 24.3% |
| Pre-Tax Income | 1.03B | 104.18M |
| Pre-Tax Income % of Revenue | 14.3% | 14.8% |
| Income Tax | 250.79M | 27.35M |
| Income Tax % of Revenue | 3.5% | 3.9% |
| Net Income (Profit) | 776.08M | 76.84M |
| Profit Margin | 10.8% | 10.9% |
Balance Sheet & Liquidity Metrics
| Metric | KRSNAA (2025) | QLL (2025) |
|---|---|---|
| Cash & Equivalents | 38.46M | 43.10M |
| Total Current Assets | 4.14B | 426.08M |
| Total Current Assets % of Revenue | 57.8% | 60.7% |
| Total Current Liabilities | 3.05B | 325.84M |
| Total Current Liabilities % of Revenue | 42.6% | 46.4% |
| Long-Term Debt | 471.56M | 308.61M |
| Long-Term Debt % of Revenue | 6.6% | 43.9% |
| Total Shareholders Equity | 8.83B | 927.82M |
| Retained Earnings | 2.00B | 145.04M |
| Retained Earnings % of Revenue | 28.0% | 20.7% |
| Property, Plant & Equipment | 256.28M | 589.98M |
Cash Flow Statement Comparison
| Metric | KRSNAA (2025) | QLL (2025) |
|---|---|---|
| Operating Cash Flow | 2.45M | 58.03M |
| Operating Cash Flow % of Revenue | 0.0% | 8.3% |
| Capital Expenditures | -1.12B | -233.17M |
| Free Cash Flow | -393.00M | -128.53M |
| FCF Margin | -5.5% | -18.3% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KRSNAA | QLL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 32.44M | 9.98M |
| Float Shares | 17.39M | 3.60M |
| % Held by Insiders | 44.56% | 65.77% |
| % Held by Institutions | 14.97% | 0.00% |
| % Held by Public | 40.47% | 34.23% |
Dividend Analysis & Yield Comparison: Krsnaa Diagnostics Ltd. vs Qualitek Labs Ltd.
| Metric | KRSNAA | QLL |
|---|---|---|
| Last 12-Month Dividend | ₹5.25 | N/A |
| Last 12-Month Dividend Yield | 0.62% | N/A |
| 3-Year Avg Annual Dividend | ₹3.50 | N/A |
| 3-Year Avg Dividend Yield | 0.39% | N/A |
| 3-Year Total Dividends | ₹10.50 | N/A |
| Ex-Dividend Date | Sep 12, 2025 | N/A |